Deciphering the recurrence-associated coding and non-coding genes in triple-negative breast cancer through genomic and transcriptomic profiling

Abstract Breast cancer exhibits significant molecular heterogeneity, with triple-negative breast cancer (TNBC) being the most biologically complex subtype, having a higher probability for recurrence and presenting greater clinical challenges. The increased mortality rate of BC patients in India might be linked to a higher prevalence of TNBC. In this study, transcriptome analysis of 24 breast tumor tissues and their corresponding adjacent tissues was conducted to understand the differential expression profile of the study cohort, which revealed 9,049 significantly differentially expressed genes (DEGs). To identify TNBC recurrence-specific molecular alterations, whole-exome sequencing and transcriptomic analyses of representative 4 recurrent and 4 non-recurrent TNBC patients were performed. The expression data identified a total of 913 DEGs in recurrent TNBC patients. Network analysis of protein-coding DEGs identified KNL1, KIF14, CKAP2L, SPC25, MCM10, and GTSE1 as key recurrence-associated hub genes. Furthermore, the identified hub genes, CKAP2L, KIF1A, KIF4A, KIF14, and MYL4 were analyzed for their prognostic significance using Kaplan-Meier Plotter based on TCGA-TNBC dataset, which revealed poor patient survival due to their elevated expression in recurrent-TNBC patients. In contrast, lower expression levels of CNTNAP2, MYL7, SNAP25, LTF, and PDCD1 showed the worst survival. Additionally, two non-coding RNAs, miR-635 and miR-647, with a significant level of their increased expression, were identified in recurrent TNBC patients. In summary, the combined analysis of exome and transcriptome data revealed pathways and central hub genes associated with recurrence, which may have prognostic and diagnostic value in patients with recurrent TNBC. These genes may be used as biomarkers to evaluate the risk of recurrence and possible targets for treatment strategies.

Authors

Institutions

Publication Details

Journal
BMC Genomic Data
Published
2026-11-14
DOI
https://doi.org/10.1186/s12863-026-01502-x
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Deciphering the recurrence-associated coding and non-coding genes in triple-negative breast cancer through genomic and transcriptomic profiling

Abhijeet P. Kulkarni, Pragati Agarwal, Kailas Dhondibhau Datkhile, Ganesh Suraj Bose et al.
BMC Genomic Data
Breast Cancer Treatment Studies
article

Deciphering the recurrence-associated coding and non-coding genes in triple-negative breast cancer through genomic and transcriptomic profiling

Abhijeet P. Kulkarni, Pragati Agarwal, Kailas Dhondibhau Datkhile, Ganesh Suraj Bose, Smriti P. K. Mittal, Suresh Bhosale, Prajakta N Reur, Sumit Aggarwal, Richa Kumari
article en

Abstract

Abstract Breast cancer exhibits significant molecular heterogeneity, with triple-negative breast cancer (TNBC) being the most biologically complex subtype, having a higher probability for recurrence and presenting greater clinical challenges. The increased mortality rate of BC patients in India might be linked to a higher prevalence of TNBC. In this study, transcriptome analysis of 24 breast tumor tissues and their corresponding adjacent tissues was conducted to understand the differential expression profile of the study cohort, which revealed 9,049 significantly differentially expressed genes (DEGs). To identify TNBC recurrence-specific molecular alterations, whole-exome sequencing and transcriptomic analyses of representative 4 recurrent and 4 non-recurrent TNBC patients were performed. The expression data identified a total of 913 DEGs in recurrent TNBC patients. Network analysis of protein-coding DEGs identified KNL1, KIF14, CKAP2L, SPC25, MCM10, and GTSE1 as key recurrence-associated hub genes. Furthermore, the identified hub genes, CKAP2L, KIF1A, KIF4A, KIF14, and MYL4 were analyzed for their prognostic significance using Kaplan-Meier Plotter based on TCGA-TNBC dataset, which revealed poor patient survival due to their elevated expression in recurrent-TNBC patients. In contrast, lower expression levels of CNTNAP2, MYL7, SNAP25, LTF, and PDCD1 showed the worst survival. Additionally, two non-coding RNAs, miR-635 and miR-647, with a significant level of their increased expression, were identified in recurrent TNBC patients. In summary, the combined analysis of exome and transcriptome data revealed pathways and central hub genes associated with recurrence, which may have prognostic and diagnostic value in patients with recurrent TNBC. These genes may be used as biomarkers to evaluate the risk of recurrence and possible targets for treatment strategies.

BMC Genomic Data
Indian Council of Medical Research (IN), Savitribai Phule Pune University (IN)
Indian Council of Medical Research, Savitribai Phule Pune University
Good health and well-being
Breast Cancer Treatment Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon